Journal of medical microbiology最新文献

{"title":"Antifungal activity of propafenone on <i>Candida</i> spp. strains: interaction with antifungals and possible mechanism of action.","authors":"Amanda Dias Barbosa, Amanda Cavalcante Leitão, Leilson Carvalho de Oliveira, Daniel Sampaio Rodrigues, Vitória Pessoa de Farias Cabral, Lara Elloyse Almeida Moreira, Maria Janielly Castelo Branco Silveira, Sarah Alves Barbosa, Beatriz Oliveira de Souza, Lívia Gurgel do Amaral Valente Sá, João Batista de Andrade Neto, Bruno Coelho Cavalcanti, Islay Lima Magalhães, Manoel Odorico de Moraes, Hélio Vitoriano Nobre Júnior, Cecília Rocha da Silva","doi":"10.1099/jmm.0.001850","DOIUrl":"https://doi.org/10.1099/jmm.0.001850","url":null,"abstract":"<p><p><b>Introduction.</b> The development of new antifungal drugs has become a global priority, given the increasing cases of fungal diseases together with the rising resistance to available antifungal drugs. In this scenario, drug repositioning has emerged as an alternative for such development, with advantages such as reduced research time and costs.<b>Gap statement.</b> Propafenone is an antiarrhythmic drug whose antifungal activity is poorly described, being a good candidate for further study.<b>Aim.</b> This study aims to evaluate propafenone activity against different species of <i>Candida</i> spp. to evaluate its combination with standard antifungals, as well as its possible action mechanism.<b>Methodology.</b> To this end, we carried out tests against strains of <i>Candida albicans</i>, <i>Candida auris</i>, <i>Candida parapsilosis</i>, <i>Candida tropicalis</i>, <i>Candida glabrata</i> and <i>Candida krusei</i> based on the evaluation of the MIC, minimum fungicidal concentration and tolerance level, along with checkerboard and flow cytometry tests with clinical strains and cell structure analysis by scanning electron microscopy (SEM).<b>Results.</b> The results showed that propafenone has a 50% MIC ranging from 32 to 256 µg ml^-1, with fungicidal activity and positive interactions with itraconazole in 83.3% of the strains evaluated. The effects of the treatments observed by SEM were extensive damage to the cell structure, while flow cytometry revealed the apoptotic potential of propafenone against <i>Candida</i> spp.<b>Conclusion.</b> Taken together, these results indicate that propafenone has the potential for repositioning as an antifungal drug.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141560581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcriptome analysis of <i>Candida albicans</i> planktonic cells in response to plasma medicine.","authors":"Xinhua Zhang, Kok Jun Liew, Li Cao, Jie Wang, Zhidong Chang, Melvin Chun Yun Tan, Kheng Loong Chong, Chun Shiong Chong","doi":"10.1099/jmm.0.001841","DOIUrl":"https://doi.org/10.1099/jmm.0.001841","url":null,"abstract":"<p><p><b>Introduction.</b> Cold plasma is frequently utilized for the purpose of eliminating microbial contaminants. Under optimal conditions, it can function as plasma medicine for treating various diseases, including infections caused by <i>Candida albicans</i>, an opportunistic pathogen that can overgrow in individuals with weakened immune system.<b>Gap Statement.</b> To date, there has been less molecular study on cold plasma-treated <i>C. albicans</i>.<b>Research Aim.</b> The study aims to fill the gap in understanding the molecular response of <i>C. albicans</i> to cold plasma treatment.<b>Methodology.</b> This project involved testing a cold plasma generator to determine its antimicrobial effectiveness on <i>C. albicans</i>' planktonic cells. Additionally, the cells' transcriptomics responses were investigated using RNA sequencing at various treatment durations (1, 3 and 5 min).<b>Results.</b> The results show that our cold plasma effectively eliminates <i>C. albicans</i>. Cold plasma treatment resulted in substantial downregulation of important pathways, such as 'nucleotide metabolism', 'DNA replication and repair', 'cell growth', 'carbohydrate metabolism' and 'amino acid metabolism'. This was an indication of cell cycle arrest of <i>C. albicans</i> to preserve energy consumption under unfavourable conditions. Nevertheless, <i>C. albicans</i> adapted its GSH antioxidant system to cope with the oxidative stress induced by reactive oxygen species, reactive nitrogen species and other free radicals. The treatment likely led to a decrease in cell pathogenicity as many virulence factors were downregulated.<b>Conclusion.</b> The study demonstrated the major affected pathways in cold plasma-treated <i>C. albicans</i>, providing valuable insights into the molecular response of <i>C. albicans</i> to cold plasma treatment. The findings contribute to the understanding of the antimicrobial efficiency of cold plasma and its potential applications in the field of microbiology.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141536199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Apramycin has high <i>in vitro</i> activity against <i>Mycobacterium tuberculosis</i>.","authors":"Qing Sun, Jun Yan, Sibo Long, Yiheng Shi, Guanglu Jiang, Hao Li, Hairong Huang, Guirong Wang","doi":"10.1099/jmm.0.001854","DOIUrl":"https://doi.org/10.1099/jmm.0.001854","url":null,"abstract":"<p><p><b>Introduction.</b> Aminoglycoside antibiotics such as amikacin and kanamycin are important components in the treatment of <i>Mycobacterium tuberculosis</i> (Mtb) infection. However, more and more clinical strains are found to be aminoglycoside antibiotic-resistant. Apramycin is another kind of aminoglycoside antibiotic that is commonly used to treat infections in animals.<b>Hypothesis.</b> Apramycin may have <i>in vitro</i> activity against Mtb.<b>Aim.</b> This study aims to evaluate the efficacy of apramycin against Mtb <i>in vitro</i> and determine its epidemiological cut-off (ECOFF) value.<b>Methodology.</b> One hundred Mtb isolates, including 17 pansusceptible and 83 drug-resistant tuberculosis (DR-TB) strains, were analysed for apramycin resistance using the MIC assay.<b>Results.</b> Apramycin exhibited significant inhibitory activity against Mtb clinical isolates, with an MIC₅₀ of 0.5 μg ml^-1 and an MIC₉₀ of 1 μg ml^-1. We determined the tentative ECOFF value as 1 µg ml^-1 for apramycin. The resistant rates of multidrug-resistant tuberculosis (MDR-TB), pre-extensively drug-resistant (pre-XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) strains were 12.12 % (4/33), 20.69 % (6/29) and 66.67 % (14/21), respectively. The <i>rrs</i> gene A1401G is associated with apramycin resistance, as well as the cross-resistance between apramycin and other aminoglycosides.<b>Conclusion.</b> Apramycin shows high <i>in vitro</i> activity against the Mtb clinical isolates, especially the MDR-TB clinical isolates. This encouraging discovery calls for more research on the functions of apramycin <i>in vivo</i> and as a possible antibiotic for the treatment of drug-resistant TB.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141556278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dengue virus (DV) non-cross-reactive Omicron wave COVID-19 serums enhanced DV3 infectivity <i>in vitro</i>.","authors":"Supratim Sarker, Chiroshri Dutta, Abinash Mallick, Sayantan Das, Chandrika Das Chowdhury, Abhishek De, Surajit Gorai, Subhajit Biswas","doi":"10.1099/jmm.0.001852","DOIUrl":"https://doi.org/10.1099/jmm.0.001852","url":null,"abstract":"<p><p><b>Introduction.</b> In India, the SARS-CoV-2 Delta wave (2020-2021) faded away with the advent of the Omicron variants (2021-present). Dengue incidences were observed to be less in Southeast Asia during the active years of the pandemic (2020-2021). However, dengue virus type 3 (DV3) cases were increasingly reported in this region (including India) concurrent with the progression of the Omicron waves since 2022.<b>Hypothesis.</b> What could be the reason(s) behind this unusual DV3 surge after an overall dip in dengue incidences in many parts of Southeast Asia?<b>Aim.</b> We, therefore, investigated the current state of cross-reactivity of prevalent (Omicron era) SARS-CoV-2 serums with different DV serotypes and evaluated the impact of such serums on DV neutralization in cell culture.<b>Methodology.</b> Fifty-five COVID-19 serum samples (January-September 2022) and three pre-pandemic archived serum samples from apparently healthy individuals were tested for DV or SARS-CoV-2 IgM/IgG using the lateral flow immunoassays. DV1-4 virus neutralization tests (VNTs) were done with the SARS-CoV-2 antibody (Ab)-positive serums in Huh7 cells. DV3 envelope (<i>env)</i> gene was PCR amplified and sequenced for three archived DV isolates, one from 2017 and two from 2021.<b>Results.</b> SARS-CoV-2 Ab-positive samples constituted 74.5 % of the serums. Of these, 41.5 % were DV cross-reactive and 58.5 % were not. The DV cross-reactive serums neutralized all DV serotypes (DV1-4), as per previous results and this study. The DV non-cross-reactive serums (58.5 %) also cross-neutralized DV1, 2 and 4 but increased DV3 infectivity by means of antibody-dependent enhancement of infection as evident from significantly higher DV3 titres in VNT compared to control serums. The DV3 envelope was identical among the three isolates, including isolate 1 used in VNTs. Our results suggest that DV cross-reactivity of SARS-CoV-2 serums diminished with the shift from Delta to Omicron prevalence. Such COVID-19 serums (DV non-cross-reactive) might have played a major role in causing DV3 surge during the Omicron waves.<b>Conclusion.</b> Patients suspected of dengue or COVID-19 should be subjected to virus/antigen tests and serological tests for both the diseases for definitive diagnosis, prognosis and disease management.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141500035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improving the diagnosis of urinary tract infections by the use of enriched media and a 48-hour incubation period.","authors":"Carla Benjumea, Ferran Navarro, Carles Alonso-Tarrés","doi":"10.1099/jmm.0.001846","DOIUrl":"10.1099/jmm.0.001846","url":null,"abstract":"<p><p><b>Introduction.</b> The absence of a gold-standard methodology for the microbiological diagnosis of urinary tract infections (UTI) has led to insufficient standardization of criteria for the interpretation of results and processing methods, particularly incubation time and culture media.<b>Hypothesis.</b> 48-hour incubation time period and use of blood agar enhances the sensitivity of microorganisms isolated significantly.<b>Aim.</b> To determine the sensitivity of blood agar and Brilliance UTI chromogenic agar, incubating for different periods (24-48 hours), for the detection of positive urine cultures.<b>Methodoloy.</b> Comparisons were made between all possible combinations of media and incubation times. As the gold-standard reference, we used the routine methodology of our laboratory, which involves prior screening with available clinical data, flow cytometry, sediment analysis and/or Gram staining. Screened samples were then cultured on blood agar and chromogenic agar and incubated for 48 hours. Also, based on the results of Gram staining, additional media were added in selected cases.<b>Results.</b> The most significant difference was found between chromogenic agar incubated for 24 hours and blood agar incubated for 48 hours, with the latter method allowing the recovery of 10.14 % more microorganisms (<i>P</i> < 0.0001). Furthermore, the value of performing Gram staining to guide processing was demonstrated, as it avoided the loss of at least 5.14 % of isolates.<b>Conclusions.</b> At least in urological and nephrological patients it is essential to include enriched culture media (blood agar) or to extend the incubation times due to the improvement of the diagnostic sensitivity of urine cultures. Gram staining also can help detect the presence of fastidious microorganisms or mixed infections, indicating whether rich and/or selective media should be included to enhance the diagnostic sensitivity of cultures. If this methodology is not followed, it should be noted that besides fastidious species, fastidious strains of <i>Escherichia coli, Proteus mirabilis, Pseudomonas aerugniosa</i> and <i>Stenotrophomonas maltophilia</i> will also be missed.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261898/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antimicrobial resistance patterns among critical priority pathogens in an intensive care unit at a tertiary hospital in Egypt: a descriptive analysis comparing pre- and COVID-19 eras.","authors":"Mai M Zafer, Dina M Bassiouny, Soumya Ghosh, Charné Bornman, Amira F A Hussein","doi":"10.1099/jmm.0.001838","DOIUrl":"10.1099/jmm.0.001838","url":null,"abstract":"<p><p><b>Background.</b> The intensified global challenge of antimicrobial resistance, set against the backdrop of the COVID-19 pandemic, is a cause for major concern. Within healthcare settings, intensive care units are recognized as focal points for Gram-negative infections. The study pursued to assess the prevalence and antimicrobial resistance patterns of critical priority pathogens (<i>Acinetobacter baumannii</i>, <i>Pseudomonas aeruginosa</i>, Enterobacteriaceae, comprising <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i>) during both pre- and COVID-19 periods.<b>Gap Statement.</b> The decision to explore this topic stemmed from the urgent need to understand how the exceptional healthcare crisis of COVID-19 affected AMR patterns.<b>Methods.</b> This was an observational retrospective analysis of 1056 clinical specimens obtained from 950 patients who were admitted to the Medical Intensive Care Unit at Kasr Al-Aini Hospital, Cairo University, Egypt.<b>Results.</b> In the period before COVID-19, 342 pathogenic isolates (135 <i>K</i>. <i>pneumoniae</i>, 83 <i>P</i>. <i>aeruginosa</i>, 76 <i>A</i>. <i>baumannii</i> and 48 <i>E. coli</i>) were obtained from samples collected from 450 patients. Conversely, during the COVID-19 period, 714 isolates (237 <i>K</i>. <i>pneumoniae</i>, 205 <i>A</i>. <i>baumannii</i>, 199 <i>P</i>. <i>aeruginosa</i> and 73 <i>E. coli</i>) were collected from the same number of patients. In the course of the pandemic, there is a slight increase in <i>A. baumannii</i> and <i>P. aeruginosa</i> infections, whereas <i>E. coli</i> and <i>K. pneumoniae</i> exhibit a distinct trend with a noticeable reduction in infection rates during COVID-19. During the COVID-19 period, a noticeable rise in resistance rates was observed for all antibiotics utilized. The results from Fisher's exact test indicated a substantial increase in resistance towards certain antibiotics. Specifically, a significant rise in resistance was observed for <i>E. coli</i> to ciprofloxacin (<i>P</i> = 0.00), gentamicin and <i>P. aeruginosa</i> (<i>P</i> = 0.02), levofloxacin and <i>A. baumannii</i> (<i>P</i> = 0.01), piperacillin-tazobactam and <i>A. baumannii</i> (<i>P</i> = 0.04), and piperacillin-tazobactam and <i>P. aeruginosa</i> (<i>P</i> = 0.01).<b>Conclusion.</b> Our results display how the pandemic impacted bacterial infections and antibiotic resistance, indicating a general increase in resistance rates. These findings are crucial for guiding healthcare practices, emphasizing the need for continued surveillance and potentially checking antibiotic usage schemes.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141447899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detection of avian reovirus (ARV) by ELISA based on recombinant σB, σC and σNS full-length proteins and protein fragments.","authors":"Tatiana Reichert Assunção de Matos, Ana Paula Gori Palka, Claudemir de Souza, Stenio Perdigão Fragoso, Daniela Parada Pavoni","doi":"10.1099/jmm.0.001836","DOIUrl":"10.1099/jmm.0.001836","url":null,"abstract":"<p><p><b>Introduction.</b> Avian reovirus (ARV) is associated with arthritis/tenosynovitis and malabsorption syndrome in chickens. The σC and σB proteins, both exposed to the virus capsid, are highly immunogenic and could form the basis for diagnostic devices designed to assess the immunological status of the flock.<b>Gap Statement.</b> Commercial ARV ELISAs cannot distinguish between vaccinated and infected animals and might not detect circulating ARV strains.<b>Aim.</b> We aimed to develop a customized test to detect the circulating field ARV strains as well as distinguish between vaccinated and unvaccinated animals.<b>Methodology.</b> We developed ELISA assays based on recombinant (r) σB, σC and the nonstructural protein σNS and tested them using antisera of vaccinated and unvaccinated chickens as well as negative controls. Fragments of σB and σC proteins were also used to study regions that could be further exploited in diagnostic tests.<b>Results.</b> Vaccinated and unvaccinated birds were positive by commercial ELISA, with no difference in optical density values. In contrast, samples of unvaccinated animals showed lower absorbance in the rσB and rσC ELISA tests and higher absorbance in the rσNS ELISA test than the vaccinated animals. Negative control samples were negative in all tests. Fragmentation of σB and σC proteins showed that some regions can differentiate between vaccinated and unvaccinated animals. For example, σB amino acids 128-179 (σB-F4) and σC amino acids 121-165 (σC-F4) exhibited 85 and 95% positivity among samples of vaccinated animals but only 5% and zero positivity among samples of unvaccinated animals, respectively.<b>Conclusion.</b> These data suggest that unvaccinated birds might have been exposed to field strains of ARV. The reduction in absorbance in the recombinant tests possibly reflects an increased specificity of our test since unvaccinated samples showed less cross-reactivity with the vaccine proteins immobilized on ELISAs. The discrepant results obtained with the protein fragment tests between vaccinated and unvaccinated animals are discussed in light of the diversity between ARV strains.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characterization of <i>Aspergillus fumigatus</i> secretome during sublethal infection of <i>Galleria mellonella</i> larvae.","authors":"Aaron Curtis, Pavel Dobes, Jacek Marciniak, Jana Hurychova, Pavel Hyrsl, Kevin Kavanagh","doi":"10.1099/jmm.0.001844","DOIUrl":"10.1099/jmm.0.001844","url":null,"abstract":"<p><p><b>Introduction.</b> The fungal pathogen <i>Aspergillus fumigatus</i> can induce prolonged colonization of the lungs of susceptible patients, resulting in conditions such as allergic bronchopulmonary aspergillosis and chronic pulmonary aspergillosis.<b>Hypothesis.</b> Analysis of the <i>A. fumigatus</i> secretome released during sub-lethal infection of <i>G. mellonella</i> larvae may give an insight into products released during prolonged human colonisation.<b>Methodology.</b> <i>Galleria mellonella</i> larvae were infected with <i>A. fumigatus,</i> and the metabolism of host carbohydrate and proteins and production of fungal virulence factors were analysed. Label-free qualitative proteomic analysis was performed to identify fungal proteins in larvae at 96 hours post-infection and also to identify changes in the <i>Galleria</i> proteome as a result of infection.<b>Results.</b> Infected larvae demonstrated increasing concentrations of gliotoxin and siderophore and displayed reduced amounts of haemolymph carbohydrate and protein. Fungal proteins (399) were detected by qualitative proteomic analysis in cell-free haemolymph at 96 hours and could be categorized into seven groups, including virulence (<i>n</i> = 25), stress response (<i>n</i> = 34), DNA repair and replication (<i>n</i> = 39), translation (<i>n</i> = 22), metabolism (<i>n</i> = 42), released intracellular (<i>n</i> = 28) and cellular development and cell cycle (<i>n</i> = 53). Analysis of the Gallerial proteome at 96 hours post-infection revealed changes in the abundance of proteins associated with immune function, metabolism, cellular structure, insect development, transcription/translation and detoxification.<b>Conclusion.</b> Characterizing the impact of the fungal secretome on the host may provide an insight into how <i>A. fumigatus</i> damages tissue and suppresses the immune response during long-term pulmonary colonization.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141249144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Levels of 5α-reductase gene in intestinal lavage fluid decrease with progression of colorectal cancer.","authors":"Tadashi Fujii, Yoshihito Nakagawa, Kohei Funasaka, Yoshiki Hirooka, Takumi Tochio","doi":"10.1099/jmm.0.001834","DOIUrl":"10.1099/jmm.0.001834","url":null,"abstract":"<p><p><b>Introduction.</b> Colorectal cancer (CRC) is a leading cause of cancer deaths, closely linked to the intestinal microbiota and bile acid metabolism. Secondary bile acids, like deoxycholic and lithocholic acid, are associated with increased CRC risk due to their disruption of vital cellular functions. In contrast, isoallolithocholic acid (isoalloLCA) shows potential health benefits, highlighting the complex role of bile acids in CRC. A specific primer set was previously developed to amplify homologs of the 5α-reductase gene (<i>5ar</i>), which are involved in the biosynthesis of isoalloLCA, thereby enabling the estimation of abundance of <i>5ar</i> (<i>5ar</i> levels) in the intestine.<b>Hypothesis/Gap Statement.</b> We hypothesized that <i>5ar</i> levels in the intestine are associated with CRC.<b>Aim.</b> This study aimed to investigate intestinal <i>5ar</i> levels and compare them across different stages of the adenoma-carcinoma sequence, providing insights into novel strategies for monitoring CRC risk.<b>Methodology.</b> DNA was extracted from intestinal lavage fluids (ILF) collected during 144 colonoscopies. Next-generation sequencing (NGS) was employed to examine the sequence of <i>5ar</i> homologues, using a specific primer set on DNA from seven selected ILFs - four from carcinoma patients and three from individuals with non-neoplastic mucosa. Additionally, we used quantitative PCR (qPCR) to measure <i>5ar</i> levels in all 144 DNA samples.<b>Results.</b> We conducted 144 colonoscopies and categorized patients according to the adenoma-cancer sequence: 52 with non-neoplastic mucosa, 69 with adenomas and 23 with carcinoma. Analysis of 292,042 NGS-derived <i>5ar</i> sequences revealed the seven most prevalent amplicon sequence variants, each 254 base pairs in length. These closely matched or were identical to <i>5ar</i> sequences in <i>Bacteroides uniformis</i>, <i>Phocaeicola vulgatus</i> and <i>Phocaeicola dorei</i>. Furthermore, qPCR analysis demonstrated significantly lower <i>5ar</i> levels in the carcinoma group compared to those in the non-neoplastic mucosa group (<i>P</i> = 0.0004). A similar, though not statistically significant, trend was observed in the adenoma group (<i>P</i> = 0.0763), suggesting that <i>5ar</i> levels decrease as CRC progresses.<b>Conclusion.</b> These findings indicate that PCR-based monitoring of <i>5ar</i> levels in intestinal samples over time could provide a non-invasive, rapid and cost-effective method for assessing an increased risk of CRC.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Colistin utilization at a tertiary hospital in South Africa: an opportunity for antimicrobial stewardship practices.","authors":"Gaalebale Prudence Matshediso, Oyewole Christopher Durojaiye, Oladele Vincent Adeniyi","doi":"10.1099/jmm.0.001840","DOIUrl":"https://doi.org/10.1099/jmm.0.001840","url":null,"abstract":"<p><p><b>Introduction.</b> Colistin (polymyxin E) has emerged as a last-resort treatment option for multidrug-resistant infections.<b>Hypothesis/Gap Statement.</b> Studies on the use, safety and efficacy of colistin in South Africa are limited.<b>Aim</b>. This study aims to describe the use of colistin and its clinical outcomes at a tertiary public hospital in South Africa.<b>Methodology.</b> We conducted a retrospective review of adult and paediatric patients who received parenteral colistin between 2015 and 2019.<b>Results.</b> A total of 69 patients (26 adults, 13 children and 30 neonates) were reviewed. <i>Acinetobacter baumannii</i> was the most common causative pathogen isolated (70.1 %). Colistin was predominately used to treat septicaemia (75.4 %). It was primarily administered as definitive therapy (71.0 %) and as monotherapy (56.5 %). It was used in 11.5 % of adults with infections susceptible to other antibiotics. Loading doses of intravenous colistin were administered in only 15 (57.7 %) adult patients. Neurotoxicity and nephrotoxicity occurred in 5.8 % and 43.5 % of patients, respectively. Clinical cure was achieved in 37 (53.6 %) patients. On multivariate logistic regression analysis, adults [adjusted odds ratio (aOR), 25.54; 95 % CI, 2.73-238.65; <i>P</i> < 0.01] and children (aOR, 8.56; 95 % CI, 1.06-69.10; <i>P</i> < 0.05) had higher odds of death than neonates.<b>Conclusion.</b> The study identified significant stewardship opportunities to improve colistin prescription and administration. Achieving optimal patient outcomes necessitates a multidisciplinary approach and vigilant monitoring of colistin use.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}